{"Symbol": "PODD", "AssetType": "Common Stock", "Name": "Insulet Corporation", "Description": "Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company is headquartered in Acton, Massachusetts.", "CIK": "1145197", "Exchange": "NASDAQ", "Currency": "USD", "Country": "USA", "Sector": "HEALTHCARE", "Industry": "MEDICAL DEVICES", "Address": "100 NAGOG PARK, ACTON, MA, UNITED STATES, 01720", "OfficialSite": "https://www.insulet.com", "FiscalYearEnd": "December", "LatestQuarter": "2025-09-30", "MarketCapitalization": "17087085000", "EBITDA": "510900000", "PERatio": "70.98", "PEGRatio": "1.843", "BookValue": "19.68", "DividendPerShare": "None", "DividendYield": "None", "EPS": "3.42", "RevenuePerShareTTM": "35.87", "ProfitMargin": "0.0976", "OperatingMarginTTM": "0.167", "ReturnOnAssetsTTM": "0.0874", "ReturnOnEquityTTM": "0.197", "RevenueTTM": "2521800000", "GrossProfitTTM": "1788700000", "DilutedEPSTTM": "3.42", "QuarterlyEarningsGrowthYOY": "0.148", "QuarterlyRevenueGrowthYOY": "0.299", "AnalystTargetPrice": "369.64", "AnalystRatingStrongBuy": "6", "AnalystRatingBuy": "18", "AnalystRatingHold": "1", "AnalystRatingSell": "0", "AnalystRatingStrongSell": "1", "TrailingPE": "70.98", "ForwardPE": "39.84", "PriceToSalesRatioTTM": "6.78", "PriceToBookRatio": "12.33", "EVToRevenue": "6.87", "EVToEBITDA": "38.4", "Beta": "1.418", "52WeekHigh": "354.88", "52WeekLow": "230.05", "50DayMovingAverage": "278.55", "200DayMovingAverage": "304.69", "SharesOutstanding": "70347000", "SharesFloat": "70108000", "PercentInsiders": "0.292", "PercentInstitutions": "102.826", "DividendDate": "None", "ExDividendDate": "None"}